United States Daily Briefing

ORCL -3.65% to $150.52 and CRM -2.56% to $196.21 headlined a broad enterprise software selloff Friday that also claimed INTC -1.97% ($102.50), CSCO -1.58% ($111.68), and TMO -1.28% ($588.29). No company-specific catalysts drove these moves — Oracle's cloud infrastructure narrative hasn't cracked, and Salesforce hasn't revised guidance — which makes the velocity of the selling notable: it reads as sector-level rotation out of high-multiple software rather than stock-specific fundamental deterioration. The outlier: AMD +6.50% to $514.39 on AI inference demand reads. The within-tech divergence is now a clear factor split — AI hardware plays maintain premium multiples while legacy cloud-SaaS names face multiple compression in a rising-rate, tighter-spending-cycle environment. Seeking Alpha upgraded KLA Corp (KLAC) to Buy after its punishing July on the same session KLAC's CEO sold $17.4M of shares (87K shares per Form 4) — the insider/analyst divergence is the most concise summary of where the Street stands on semis right now.

Chevron +1.16% to $200.00 and ExxonMobil +0.94% to $160.10 anchored a sector-wide energy bid, with Energy's +1.39% standing as the session's top-performing sector by a wide margin. The broader read from today's sector tape: Utilities +0.61%, Real Estate +0.33%, Materials +0.44%, Comm. Services +0.36% — four defensive and real-asset sectors all positive while Tech and Healthcare both closed red. That is not noise; it is late-cycle positioning showing up in the ETF flows. The factor rotation away from MTUM toward SPLV, XLE over XLK, is the dominant regime read. Corvex Management's Q2 13F reinforces the theme: the fund added Vistra (VST, clean energy) and Planet Fitness (PLNT, consumer value) while exiting CoStar and Lionsgate — institutional capital rotating out of growth optionality toward real earnings and dividend cover, exactly what the sector tape is pricing today.

Q2 13F filings hit Thursday and Friday and institutional positioning reads reinforce the defensive-quality rotation. Glenview Capital, per Seeking Alpha's filing analysis, opened new stakes in Eli Lilly (LLY) and AbbVie (ABBV) while exiting DXC Technology, ZoomInfo, and Lithia Motors — a pivot into biopharma mega-caps with durable revenue streams and visible earnings paths over 2026-2027. Trimmed positions include CVS and Applied Materials (AMAT), suggesting neither the pharmacy-benefit-manager narrative nor semi-equipment capex thesis clears the bar at current multiples. On the crypto side, Seeking Alpha reported that Coinbase, Ripple, Kalshi, and a16z executives are expected at a White House meeting next week as the CFTC launches its Innovation Advisory Committee. Institutional legitimacy for digital assets continues to build; Bitcoin's role as macro hedge vs. gold will be worth tracking into next week, particularly if Treasury 10-year yields re-test the 4.40-4.50% range on any Fed commentary.